Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04129502 |
|---|---|
| Brief Title: | TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations |
| First Submitted : | October 7, 2019 |
| First Submitted that Met QC Criteria : | October 15, 2019 |
| First Posted : | October 16, 2019 |
| Last Update Submitted that Met QC Criteria : | May 17, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |